GAIN
Q3 2026 EPS Estimate
$0.24
Aug 11, 2026 · Reports before open
Revenue Estimate
$25M
FY2027E EPS$0.87
FY2028E EPS$0.93

Analyst Sentiment

Wall St. Consensus
Hold
7 analysts·Limited coverage
57
Score
2 Buy (29%)5 Hold (71%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
229%
Hold
571%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$17.00
+8.2%
Consensus
$17.00
+8.2%
Bull
$17.00
+8.2%
12-Month Target Range7 analysts
$17.00$17.00$17.00
Current $15.71Consensus
Current Price
$15.71
Upside to Consensus
$1.29

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+5.93%
EPS+114.26%
FY2028
Rev+7.37%
EPS+6.64%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2027EFY2028E
Revenue Avg$106M$113M
Low$104M$108M
High$107M$119M
EBITDA Avg$94M$101M
Low$93M$96M
High$95M$106M
EBIT Avg$89M$95M
Low$88M$91M
High$90M$100M
Net Income Avg$35M$37M
Low$32M$34M
High$36M$37M
EPS Avg$0.87$0.93
Low$0.83$0.89
High$0.92$0.97
Analysts (Rev / EPS)3 / 33 / 3
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028
Revenue Avg$26M$27M$27M$28M$28M$29M$29M
Low$26M$26M$27M$27M$28M$28M$29M
High$26M$27M$28M$28M$29M$29M$30M
EBITDA Avg$23M$24M$24M$25M$25M$26M$26M
Low$23M$24M$24M$24M$25M$25M$25M
High$23M$24M$25M$25M$26M$26M$26M
EBIT Avg$22M$22M$23M$23M$24M$24M$24M
Low$22M$22M$23M$23M$23M$24M$24M
High$22M$23M$23M$24M$24M$25M$25M
Net Income Avg$9M$9M$9M$9M$9M$9M$9M
Low$8M$9M$9M$9M$9M$9M$9M
High$9M$9M$9M$9M$9M$10M$10M
EPS Avg$0.21$0.22$0.22$0.23$0.23$0.24$0.24
Low$0.21$0.21$0.22$0.22$0.23$0.23$0.23
High$0.22$0.22$0.23$0.23$0.24$0.24$0.24
Analysts (Rev / EPS)3 / 32 / 11 / 12 / 12 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

May 14, 2026Oppenheimer
Gladstone Investment price target raised to $17 from $15 at Oppenheimer
Target:$17.00
+1.9%from $16.68
Feb 4, 2026Oppenheimer
Gladstone Investment price target raised to $15 from $14 at Oppenheimer
Target:$15.00
+5.0%from $14.29
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.